Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2015 1
2016 3
2017 1
2018 1
2019 4
2020 3
2021 5
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Treatment Initiation in Patients with Interstitial Lung Disease in Canada.
Assayag D, Garlick K, Johannson KA, Fell CD, Kolb M, Cox G, Hambly N, Manganas H, Morisset J, Fisher JH, Shapera S, Gershon AS, To T, Sadatsafavi M, Wilcox PG, Halayko AJ, Khalil N, Ryerson CJ. Assayag D, et al. Among authors: manganas h. Ann Am Thorac Soc. 2021 Oct;18(10):1661-1668. doi: 10.1513/AnnalsATS.202009-1122OC. Ann Am Thorac Soc. 2021. PMID: 33493425
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
Tsai APY, Hur SA, Wong A, Safavi M, Assayag D, Johannson KA, Morisset J, Fell C, Fisher JH, Manganas H, Shapera S, Cox G, Gershon AS, Hambly N, Khalil N, To T, Wilcox PG, Halayko A, Kolb MR, Ryerson CJ. Tsai APY, et al. Among authors: manganas h. Thorax. 2021 Jan;76(1):37-43. doi: 10.1136/thoraxjnl-2020-214944. Epub 2020 Oct 6. Thorax. 2021. PMID: 33023996
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.
Chen T, Tsai APY, Hur SA, Wong AW, Sadatsafavi M, Fisher JH, Johannson KA, Assayag D, Morisset J, Shapera S, Khalil N, Fell CD, Manganas H, Cox G, To T, Gershon AS, Hambly N, Halayko AJ, Wilcox PG, Kolb M, Ryerson CJ. Chen T, et al. Among authors: manganas h. Respir Res. 2021 Jul 8;22(1):202. doi: 10.1186/s12931-021-01790-0. Respir Res. 2021. PMID: 34238283 Free PMC article.
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW, Lee TY, Johannson KA, Assayag D, Morisset J, Fell CD, Fisher JH, Shapera S, Gershon AS, Cox G, Halayko AJ, Hambly N, Manganas H, Sadatsafavi M, Wilcox PG, To T, Marcoux V, Khalil N, Kolb M, Ryerson CJ. Wong AW, et al. Among authors: manganas h. Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7. Respir Res. 2020. PMID: 33287805 Free PMC article.
Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease-associated Interstitial Lung Disease.
Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ. Algamdi M, et al. Among authors: manganas h. Ann Am Thorac Soc. 2020 Sep;17(9):1077-1084. doi: 10.1513/AnnalsATS.201911-822OC. Ann Am Thorac Soc. 2020. PMID: 32437249
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH, Kolb M, Algamdi M, Morisset J, Johannson KA, Shapera S, Wilcox P, To T, Sadatsafavi M, Manganas H, Khalil N, Hambly N, Halayko AJ, Gershon AS, Fell CD, Cox G, Ryerson CJ. Fisher JH, et al. Among authors: manganas h. BMC Pulm Med. 2019 Nov 27;19(1):223. doi: 10.1186/s12890-019-0986-4. BMC Pulm Med. 2019. PMID: 31771541 Free PMC article.
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis.
Khalil N, Manganas H, Ryerson CJ, Shapera S, Cantin AM, Hernandez P, Turcotte EE, Parker JM, Moran JE, Albert GR, Sawtell R, Hagerimana A, Laurin P, Gagnon L, Cesari F, Kolb M. Khalil N, et al. Among authors: manganas h. Eur Respir J. 2019 Mar 18;53(3):1800663. doi: 10.1183/13993003.00663-2018. Print 2019 Mar. Eur Respir J. 2019. PMID: 30578394 Free PMC article. Clinical Trial.
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease.
Goobie GC, Ryerson CJ, Johannson KA, Schikowski E, Zou RH, Khalil N, Marcoux V, Assayag D, Manganas H, Fisher JH, Kolb MRJ, Gibson KF, Kass DJ, Zhang Y, Lindell KO, Nouraie SM. Goobie GC, et al. Among authors: manganas h. Am J Respir Crit Care Med. 2022 Feb 15;205(4):459-467. doi: 10.1164/rccm.202109-2065OC. Am J Respir Crit Care Med. 2022. PMID: 34818133
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.
Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ. Algamdi M, et al. Among authors: manganas h. Chest. 2019 Nov;156(5):887-895. doi: 10.1016/j.chest.2019.04.016. Epub 2019 Apr 30. Chest. 2019. PMID: 31051170 Free article.
25 results